Virtus Biotech Clinical Trials ETF · $33M$10,290
BBCBBC vsARKGARKGARK Genomic Revolution ETF · $2.2B$6,752
$10,000 five years ago, dividends reinvested · they hold 7.0% in common
BBCMeasureARKG
Returns · dividends reinvested
+13.1%Year to dateJan 1 → Nov 4+71.5%
+43.3%1 yearTotal return+62.1%
+37.4%3 years · per year$10,000 became $25,933 · $22,153+30.4%
+0.6%5 years · per year$10,000 became $10,290 · $6,752−7.6%
Cost and income
0.65%Expense ratio$65 · $75 a year on $10k · lower is better0.75%
1.50%Trailing 12-mo yield$150 · $0 a year on $10k0.00%
Risk · past year
−30.2%Worst dropSmaller is better−27.5%
37.6%VolatilityLower is calmer45.8%
BBCARKG Winner of the row, in its colourEach row: the bigger of the two fills its side
5–3BBC wins
End-of-day Nov 4, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns